92 related articles for article (PubMed ID: 14990053)
41. BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
Brauer KM; Werth D; von Schwarzenberg K; Bringmann A; Kanz L; Grünebach F; Brossart P
Cancer Res; 2007 Jun; 67(11):5489-97. PubMed ID: 17545631
[TBL] [Abstract][Full Text] [Related]
42. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
43. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
[TBL] [Abstract][Full Text] [Related]
44. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
Brassat U; Balabanov S; Bali D; Dierlamm J; Braig M; Hartmann U; Sirma H; Günes C; Wege H; Fehse B; Gontarewicz A; Dikomey E; Borgmann K; Brümmendorf TH
Exp Hematol; 2011 Jan; 39(1):66-76.e1-2. PubMed ID: 20940029
[TBL] [Abstract][Full Text] [Related]
45. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
[TBL] [Abstract][Full Text] [Related]
46. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
47. Detection of stem cell factor mRNA expression in leukemic cells by in situ reverse transcriptase-PCR.
Wu B; Liu XL; Xuan WL; Feng R; Yin F; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):490-2. PubMed ID: 12297464
[TBL] [Abstract][Full Text] [Related]
48. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression].
Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway.
Wu LX; Xu JH; Wu GH; Chen YZ
Acta Pharmacol Sin; 2003 Nov; 24(11):1155-60. PubMed ID: 14627502
[TBL] [Abstract][Full Text] [Related]
50. Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia.
Chow LM; Chui CH; Tang JC; Teo IT; Lau FY; Cheng GY; Wong RS; Leung TW; Lai KB; Yau MY; Gou D; Chan AS
Oncol Rep; 2003; 10(5):1601-7. PubMed ID: 12883747
[TBL] [Abstract][Full Text] [Related]
51. [Expression and role of cyclin D3 in childhood acute leukemia].
Zhang L; Li J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):347-9. PubMed ID: 11721429
[TBL] [Abstract][Full Text] [Related]
52. [Regulative effects of ERK and P38 signal transduction pathway on cell cycle in chronic myeloid leukemia].
Guo X; Pan L; Hou LF; Wang YJ; Guo HM; Yang L; Wang ZW; Sun Y; Li DL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):242-7. PubMed ID: 17493324
[TBL] [Abstract][Full Text] [Related]
53. [Biological characteristics of Wt1 gene in relation to Ph(+) leukemia cell line K562].
Li Y; Li XY; Wang L; Tian Z; Rao Q; Jia HR; Wang HJ; Wang M; Mi YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):564-9. PubMed ID: 20561402
[TBL] [Abstract][Full Text] [Related]
54. [CML cell line K562 cell apoptosis induced by mangiferin].
Peng ZG; Luo J; Xia LH; Chen Y; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):590-4. PubMed ID: 15498116
[TBL] [Abstract][Full Text] [Related]
55. Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway.
Li B; Sun B; Zhu J; Zhou N; Yang Z; Gu J
Tumour Biol; 2014 Oct; 35(10):10057-66. PubMed ID: 25015191
[TBL] [Abstract][Full Text] [Related]
56. [Effect of heat stress on expression of gp96 in K562 cell line of the chronic myeloid leukemia and its significance].
Wang X; Shi B; Wang SW; Dong JQ; Cui JY; Han SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):667-72. PubMed ID: 16928296
[TBL] [Abstract][Full Text] [Related]
57. Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells.
Aoki S; Kong D; Matsui K; Kobayashi M
Anticancer Drugs; 2004 Apr; 15(4):363-9. PubMed ID: 15057141
[TBL] [Abstract][Full Text] [Related]
58. Antiproliferative effect of aaptamine on human chronic myeloid leukemia K562 cells.
Jin M; Zhao W; Zhang Y; Kobayashi M; Duan H; Kong D
Int J Mol Sci; 2011; 12(11):7352-9. PubMed ID: 22174603
[TBL] [Abstract][Full Text] [Related]
59. [The expression and role of the transcription factor C/EBPα in chronic myeloid leukemia].
Zhang G; Dong F; Luan C; Zhang X; Shao H; Liu J; Sun C
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):947-50. PubMed ID: 26632469
[TBL] [Abstract][Full Text] [Related]
60. eIF3b regulates the cell proliferation and apoptosis processes in chronic myelogenous leukemia cell lines via regulating the expression of C3G.
Huang L; Wei Z; Chang X; Zheng X; Yan J; Huang J; Zhang J; Sheng L
Biotechnol Lett; 2020 Jul; 42(7):1275-1286. PubMed ID: 32236758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
